You searched for "eye drop"
“My cataracts have been dissolved by eye drops!”
1 April 2018
|
EYE - Cataract, EYE - Refractive
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are scientific reality and which are ‘fake news’. Headline: “My cataracts have been dissolved by eye drops!” I’m sure some of us have had patients enquire...
My Top Five: Emerging technologies revolutionising ophthalmology
3 October 2024
| Khaled Saqqaw
|
Retina / Uvea / Vitreous, Cataract and Refractive, Cornea / External Eye Disease
Advancements in ophthalmology have significantly transformed eyecare practices. This article explores five emerging technologies that are revolutionising the field, from virtual reality (VR) surgical training to novel therapies for corneal conditions. These innovations are reshaping how eyecare professionals diagnose, treat...
Developing eye health services in Malawi: a personal reflection
3 June 2024
| Chinsisi Namate Nyirenda, Covadonga Bascaran
|
Ophthalmology, EYE - Glaucoma, EYE - Cataract, EYE - Refractive
Dr Chinsisi Namate reflects on her first two years as a consultant ophthalmologist at the eye unit at Zomba Central Hospital, and how she has already successfully expanded eyecare services for southeast Malawi. The Lions Sight First Eye Hospital in...
Headache: the clue is in the eyes
1 October 2021
| Parushak Rezai, Aleksandra Pekacka
|
Ophthalmology, EYE - Neuro-ophthalmology, EYE - Imaging
A worrying cause of headache is raised intracranial pressure (ICP). Papilloedema is a vital clue for accurate diagnosis and performing fundoscopy is essential in detecting this sign. The authors review the use of fundoscopy in their own district general hospital....
Natural regression of brow heaviness in thyroid eye disease
This is a retrospective review of the change over time in the sub-brow fat volume in 104 patients with thyroid eye disease. Standardised photographs taken at diagnosis were compared with those taken after an average period of 10 years (+/-...The assessment of pupils and pupillary reactions
1 October 2015
| Li Yen Goh
|
EYE - Vitreo-Retinal
Understanding pupillary reactions is vital in understanding basic neuro-opthalmology. It is a skill required in eye casualty, clinics and perhaps most importantly, exams. To start at the beginning, the pupil is the central aperture of the iris, its size controlling...
En coup de sabre scar and strabismus
4 February 2021
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
|
Linear scleroderma, en coup de saber, fibrosis, strabismus fixus
This is a case report of an eight-year-old child with gradual progressive strabismus (esotropia and hypotropia) from the age of five years. The angle measured >45 degrees esotropia and 10 degrees hypotropia. There was a depressed linear-localised scar over the...
Improving cataract efficiency: insights and learnings from expert practitioners
1 December 2022
| Rod McNeil, Qasim Mansoor, Alexander Ionides
|
Ophthalmology, EYE - Cataract, EYE - Refractive
An evening surgical meeting sponsored by Théa Pharmaceuticals Ltd brought together leading experts to share insights and experience on practice strategies to enhance the efficiency of cataract surgery. Streamlining patient flow to optimise capacity and efficiency Qasim Mansoor, Consultant Ophthalmic...
What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace
Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...Periocular burns: a literature review of classification, management protocols and outcomes of treatment
The author provides a review of the current literature regarding the principles of classification, management protocols of acute ocular and periocular burns and the role of the burn and oculoplastic surgeon involved in their care. More than two-thirds of facial...Optimising the ocular surface by managing meibomian gland dysfunction
1 February 2016
| Teifi James
|
EYE - Cornea
Meibomian gland dysfunction (MGD) is ubiquitous. Ocular surface inflammation and irritation are prevalent in most ophthalmology clinics: corneal, cataract, glaucoma, oculoplastic, paediatric, vitreo-retinal, medical retina and refractive surgery. These patients also represent roughly one third of those attending for emergency...
Contemporary glaucoma therapy: spoilt for choice
1 April 2014
| Rod McNeil
|
EYE - Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...